share_log

InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease

InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease

inmed pharmaceuticals宣布INm-901口服制剂将用于其阿尔茨海默病开发项目中。
Benzinga ·  08/20 07:37

InMed Pharmaceuticals Announces INM-901 As An Oral Formula That Will Be Used In Its Development Programs For Alzheimer's Disease

inmed pharmaceuticals宣布INm-901口服制剂将用于其阿尔茨海默病开发项目中。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发